SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

KPRX

Kiora Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 2.40 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 8, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 19, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 7, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record84615 flagged findings
Reported transactions (Form 4)71since Mar 3, 2023
Corporate events (8-K)30since Apr 26, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

2 reverse splits in 5 years (1:40 on Sep 27, 2022, 1:9 on Jun 11, 2024) · 1:360 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 846)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 17, 26SCHEDULE 13G ↗Passive stake · Baselake Partners, LP · 5.8% · event on Sep 10, 26
  • Sep 17, 26Form 4 ↗Insider transaction
  • Sep 17, 26Form 3 ↗Insider transaction
  • Sep 8, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 19, 268-K ↗Current report · Entered a material agreement
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · ADAR1 Capital Management, LLC · 9.9% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Nantahala Capital Management, LLC · 10.0% · event on Jun 30, 26 · amendment
  • Aug 10, 26SCHEDULE 13G ↗Passive stake · Perceptive Advisors LLC · 10.0% · event on Apr 6, 26
  • Aug 7, 268-K ↗Current report · Results
  • Aug 7, 2610-Q ↗Quarterly report
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jun 18, 268-K ↗Current report · Communication to the market
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Jun 11, 268-K ↗Current report · A senior executive left or was appointed
  • May 28, 26424B3 ↗Securities offering
  • May 20, 26CORRESP ↗Correspondence with the SEC
  • May 20, 26UPLOAD ↗Correspondence with the SEC
  • May 18, 26S-3 ↗Securities offering
  • May 15, 26SCHEDULE 13G ↗Passive stake · Alyeska Investment Group, L.P. · 10.0% · event on Mar 31, 26

846 filings on record, the oldest from Jun 12, 14.

Listing the 25 most recent filings of the 846 on record.

8-Ks, explained

Stress12Structure41Governance36
  • Sep 8, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 19, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 11, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 7, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 2, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 3, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 15, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 1, 24GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Feb 1, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jan 31, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 16, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 21, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

14 older filings not shown · The record reaches back to Jul 10, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Jul 20, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 25, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 31, 22StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • May 23, 22StressPast accounts declared unreliable and being restated+1 more in the same filing8-K 4.02 ↗
  • Feb 28, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Mar 22, 19StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 25, 18StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Mar 22, 18StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 22, 17StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 12 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Nantahala Capital Management, LLC10.0%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Perceptive Advisors LLC10.0%Apr 6, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Alyeska Investment Group, L.P.10.0%Mar 31, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • ADAR1 Capital Management, LLC9.9%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Rosalind Advisors, Inc.9.9%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
show 3 more holdershide
  • Baselake Partners, LP5.8%Sep 10, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Orin Hirschman4.9%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP3.4%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 11, 24Buy$5KCarmine N. Stengone↗
  • Sep 10, 24Buy$11KAron Shapiro↗
  • Aug 19, 24Buy$20KPRAVEEN TYLE↗
  • Aug 19, 24Buy$5KLisa Walters-Hoffert↗
  • Aug 14, 24Buy$6KMelissa ToscaCFO↗
  • Jun 14, 24Buy$8KEric Joseph DanielsChief Development Officer↗
  • Jun 14, 24Buy$525Melissa ToscaEVP Finance↗
  • Jun 13, 24Buy$15KBrian M. StremPresident and CEO↗
  • Jun 13, 24Buy$26KErin Parsons↗
Stock compensation, tax and giftsshow the 22 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 1, 26Tax$5KBrian M. StremPresident and CEO↗
  • Jul 1, 26Tax$2KMelissa ToscaCFO↗
  • Apr 1, 26Tax$4KBrian M. StremPresident and CEO↗
  • Apr 1, 26Tax$2KEric Joseph DanielsChief Development Officer↗
  • Apr 1, 26Tax$2KMelissa ToscaCFO↗
  • Mar 6, 26Compensationamount n/aMelissa ToscaCFO↗
  • Mar 6, 26Compensationamount n/aBrian M. StremPresident and CEO↗
  • Mar 6, 26Compensationamount n/aEric Joseph DanielsChief Development Officer↗
  • Mar 3, 26Tax$481Brian M. StremPresident and CEO↗
  • Mar 3, 26Tax$481Eric Joseph DanielsChief Development Officer↗
  • Apr 1, 25Compensationamount n/aBrian M. StremPresident and CEO↗
  • Apr 1, 25Compensationamount n/aEric Joseph DanielsChief Development Officer↗
  • Apr 1, 25Compensationamount n/aMelissa ToscaCFO↗
  • Jul 1, 24Compensationamount n/aEric Joseph DanielsChief Development Officer↗
  • Jul 1, 24Compensationamount n/aMelissa ToscaCFO↗
  • Jul 1, 24Compensationamount n/aBrian M. StremPresident and CEO↗
  • Sep 29, 23Compensationamount n/aBrian M. StremPresident and CEO↗
  • Sep 29, 23Compensationamount n/aEric Joseph DanielsChief Development Officer↗
  • Sep 29, 23Compensationamount n/aMelissa ToscaEVP Finance↗
  • Mar 3, 23Compensationamount n/aEric Joseph DanielsChief Development Officer↗
  • Mar 3, 23Compensation$60KBrian M. StremPresident and CEO↗
  • Mar 3, 23Compensationamount n/aMelissa ToscaEVP Finance↗

The full record holds 31 transactions and goes back to Mar 3, 23.

Its sector and its market

Kiora Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Kiora Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Kiora Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
846 documents on file, from Jun 12, 2014 to Sep 17, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.